News for XBiotech, Inc. (XBIT)

News for XBiotech, Inc.
Date Headline
Oct 05, 2018 08:00 AM XBiotech Announces Enrollment Completion in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Atopic Dermatitis
Sep 26, 2018 08:00 AM XBiotech Announces Granting of European Patent for Treatment of Inflammatory Skin Diseases
Sep 24, 2018 08:30 AM XBiotech Announces Completion of U.S. Enrollment in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Hidradenitis Suppurativa
Sep 20, 2018 08:00 AM XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team
Sep 13, 2018 08:00 AM XBiotech Announces Completion and Positive Interim Findings for Initial Cohort in Bermekimab Pilot Study in Atopic Dermatitis
Sep 12, 2018 08:00 AM XBiotech Announces Addition of World Leading Cardiologist Dr. Peter Libby to its Scientific Advisory Board
Aug 27, 2018 08:00 AM XBiotech Announces Publication of Breakthrough Findings for Potential Role of Interleukin-1 alpha in Risk for Heart Attacks
Aug 10, 2018 08:00 AM XBiotech Highlights Quarterly Developments
Jul 10, 2018 08:01 AM XBiotech Announces First Patient in Phase 2 Study Evaluating Subcutaneous MABp1 in Patients with Hidradenitis Suppurativa
May 22, 2018 08:01 AM XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis